(Q28378707)

English

In vitro antimicrobial activity of a new antibiotic, MDL 62,879 (GE2270 A)

scientific article

In more languages

edit

Statements

instance of

scholarly article

0 references

title

In vitro antimicrobial activity of a new antibiotic, MDL 62,879 (GE2270 A) (English)

0 references

author name string

B P Goldstein

series ordinal

1

0 references

M Berti

series ordinal

2

0 references

F Ripamonti

series ordinal

3

0 references

A Resconi

series ordinal

4

0 references

R Scotti

series ordinal

5

0 references

M Denaro

series ordinal

6

0 references

language of work or name

English

0 references

publication date

April 1993

0 references

published in

Antimicrobial Agents and Chemotherapy

0 references

volume

37

0 references

issue

4

0 references

page(s)

741-5

0 references

cites work

Mutations of Bacteria from Virus Sensitivity to Virus Resistance

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187747

retrieved

20 March 2017

Antibiotic GE2270 a: a novel inhibitor of bacterial protein synthesis. I. Isolation and characterization

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187747

retrieved

20 March 2017

In vitro activity of MDL 62,879 (GE2270 A) against aerobic gram-positive and anaerobic bacteria

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187747

retrieved

29 September 2017

New antibiotic that acts specifically on the GTP-bound form of elongation factor Tu.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187747

retrieved

29 September 2017

Bacterial challenges and evolving antibacterial drug strategy

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187747

retrieved

29 September 2017

Methicillin-resistant Staphylococcus aureus--a reappraisal

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187747

retrieved

2 June 2018

Vancomycin-resistant bacteria

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187747

retrieved

2 June 2018

Inhibition of bacterial protein synthesis by elongation-factor-Tu-binding antibiotics MDL 62,879 and efrotomycin

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187747

retrieved

2 June 2018

Identifiers

0 references

0 references

PubMed publication ID

8494369

0 references

ResearchGate publication ID

14705685

0 references

(Q28378707)

In vitro antimicrobial activity of a new antibiotic, MDL 62,879 (GE2270 A)

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)